Myostan (YK-11) Driada Medical EU

YK-11 (Myostan) - Driada Medical EU

The provided text details YK-11, an oral compound often classified as a Selective Androgen Receptor Modulator (SARM), though its unique action has led some researchers to classify it separately.¹ It is known for its strong anabolic effects, primarily through inhibiting the muscle-limiting protein myostatin.²

 Note: YK-11 is an investigational compound not approved for human use and is banned by major sports organizations (WADA).³ Its potential side effects, including liver damage and cancer risk, are severe.⁴

Mechanism of Action

YK-11 is described as an oral SARM steroid that acts as a gene-specific partial activator of androgen receptors (AR).⁵

• Dual Action:

  1. Partial AR Activation: It supports muscle growth and bone density (anabolic effects) via androgen receptors.⁶

  2. Myostatin Inhibition (Unique): YK-11 uniquely stimulates the production of follistatin.⁷ Follistatin then blocks myostatin, a protein that naturally limits muscle growth.⁸ By inhibiting myostatin, YK-11 promotes enhanced muscle growth and strength.⁹

Key Benefits

• Extreme Anabolism: Promotes muscle growth by bypassing the body's natural genetic limits on muscle size (myostatin inhibition).

• Strength Gains: Enhances strength significantly due to increased muscle mass.

• Oral Administration: Convenient oral form.

Usage and Dosage Guidelines

• Suggested Dosage: 5 mg daily, taken orally.

• Cycle Length (Common Illicit Use): Cycles are typically kept short (4–8 weeks) due to the compound's potency and unknown long-term risks.

Potential Side Effects and Risks

YK-11 is a potent compound with severe associated risks:

• Endocrine Disruption: Testosterone suppression is a possible side effect. Post-Cycle Therapy (PCT) would be required.

• Toxicity: Possible side effects include liver damage.¹⁰ Users should monitor liver enzymes.

• Severe Risks: Overuse may lead to cancer.

• General Side Effects: Acne, reduced libido, insomnia, anxiety, nausea, and vomiting.

• Interactions: May interact with other SARMs.

Frequently Asked Questions (FAQ)

1. What is the unique mechanism that distinguishes YK-11 from other SARMs like Ostarine?

YK-11 is unique because it acts as a myostatin inhibitor.¹¹ It stimulates the production of follistatin, which blocks the myostatin protein, thereby overcoming the body's natural genetic limits on muscle growth.¹²

2. What is the recommended daily dosage for YK-11?

The suggested dosage is 5 mg daily, taken orally.

3. What are the most severe potential health risks associated with YK-11 overuse?

The most severe potential health risks noted are liver damage and the risk that overuse may lead to cancer.

4. What must a user plan for after completing a cycle of YK-11?

Due to the risk of testosterone suppression, the user must plan for a Post-Cycle Therapy (PCT) protocol to restore natural hormone production.